| Prev Close: | 0.18 |
|---|---|
| Open: | N/A |
| Bid: | 0.19 |
| Ask: | 0.20 |
| 1y Target Est: | N/A |
| Beta: | -0.16 |
| Next Earnings Date: | 26-Aug-13 |
| Day's Range: | 0.18 - 0.18 |
|---|---|
| 52wk Range: | 0.15 - 0.30 |
| Volume: | 0 |
| Avg Vol (3m): | 7,803 |
| Market Cap: | 7.82M |
| P/E (ttm): | N/A |
| EPS (ttm): | N/A |
| Div & Yield: | 3.84 (4.30%) |
Quotes delayed, except where indicated otherwise. Currency in CAD.
Headlines
- Theralase Releases Financial Results for First Quarter 2013Accesswire(Thu, May 30)
- Theralase Launches New Head Office and Therapeutic Laser CentreAccesswire(Tue, May 28)
- Theralase Advanced Cancer Therapy Research Recognized at Major International ConferenceAccesswire(Thu, May 16)
- Theralase Announces 2012 Year End Financials; Theralase Advances Therapeutic Laser and Cancer Destruction TechnologiesAccesswire(Wed, May 1)
- Theralase's Innovative Anti-Cancer Technology Validated at Major International ConferencesAccesswire(Fri, Apr 19)
- Theralase Applies to TSX Venture Exchange for Warrant ExtensionAccesswire(Thu, Mar 28)
- Theralase Achieves Commercialization Milestone For Its Bladder Cancer TherapyAccesswire(Thu, Mar 14)
- Theralase Expands Board of Directors with Strong Financing CapabilitiesAccesswire(Fri, Feb 1)
- Renowned Oncologist Dr. Michael Jewett Joins Theralase's Medical and Scientific Advisory BoardAccesswire(Tue, Jan 29)
Press Releases
- Theralase Releases Financial Results for First Quarter 2013Accesswire(Thu, May 30)
- Theralase Launches New Head Office and Therapeutic Laser CentreAccesswire(Tue, May 28)
- Theralase Advanced Cancer Therapy Research Recognized at Major International ConferenceAccesswire(Thu, May 16)
Reports
- Thomson Reuters Stock Report - THERALASE TECHNOLOGIES INC. (TLT-V)Thomson Reuters Stock Report(Jun 18)
- Theralase Technologies Inc: Business description, financial summary, 3yr and...Reuters Investment Profile(Jun 15)
- Theralase Technologies, Inc. (TLT) - Medical Equipment - Deals and Alliances...GlobalData(May 23)